Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML)
ACS Med Chem Lett
.
2021 Jan 11;12(2):170-171.
doi: 10.1021/acsmedchemlett.0c00669.
eCollection 2021 Feb 11.
Author
Ram W Sabnis
1
Affiliation
1
Smith, Gambrell & Russell LLP, 1230 Peachtree Street NE, Suite 3100, Atlanta, Georgia 30309, United States.
PMID:
33603957
PMCID:
PMC7883377
DOI:
10.1021/acsmedchemlett.0c00669
No abstract available
Publication types
Editorial